Intra-arterial Thrombolysis in Acute Ischemic Stroke

Stroke: Pathophysiology, Diagnosis, and Management

Volumn , Issue , 2004, Pages 943-951

  Furlan, Anthony J ^a   Higashida, Randall ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 32844455368     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B0-44-306600-0/50057-2     Document Type: Chapter

References (83)

1. Nenci GG, Gresele P, Taramelli M, et al. Thrombolytic therapy for thromboembolism of vertebrobasilar artery. Angiology 1983, 34:561-571.
2. del Zoppo GJ, Ferbert A, Otis S, et al. Local intra-arterial fibrinolytic therapy in acute carotid territory stroke: A pilot study. Stroke 1988, 19:307-313.
3. Hacke W, Zeumer H, Ferbert A, et al. Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. Stroke 1988, 19:1216-1222.
4. Accreditation Council for Graduate Medical Education Program Requirements for Residence Education in Endovascular Surgical Neuroradiology. Available online at . http://www.ACGME.org/RRC_progREQ/.
5. Zeumer H, Freitag HJ, Zanella F, et al. Local intra-arterial fibrinolytic therapy in patients with stroke: Urokinase versus recombinant tissue plasminogen activator (rt-PA). Neuroradiology 1993, 35:159-162.
6. Nesbit GM, Clark WM, O'Neil OR, Barnwell SL Intracranial intra-arterial thrombolysis facilitated by microcatheter navigation through an occluded cervical internal carotid artery. J Neurosurg 1996, 84:387-392.
7. Adams HP, Brott TC, Furlan AJ, et al. Guidelines for thrombolytic therapy for acute stroke: A supplement to the guidelines for the management of patients with acute ischemic stroke. A Statement for Healthcare Professionals from a Special Writing Group of the Stroke Council, American Heart Association. Stroke 1996, 27:1711-1718.
8. del Zoppo GJ, Higashida RT, Furlan AJ, et al. PROACT: A Phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke 1998, 29:4-11.
9. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke-The PROACT II Study: A randomized controlled trial. JAMA 1999, 282:2003-2011.
10. Higashida RT, Halbach VV, Tsai FY, et al. Interventional neurovascular techniques in acute thrombolytic therapy for stroke. Thrombolytic Therapy in Acute Ischemic Stroke III 1995, 294-300. Springer-Verlag, Tokyo. T. Yamagushi, E. Mori, K. Minematsu, G.J. del Zoppo (Eds.).
11. Consensus Conference on Current Strategies for Intracerebral Fibrinolysis for Acute Stroke Therapy Memphis, TN, Presented at Centocor, January 8-9, 2000.
12. Abciximab in acute ischemic stroke A randomized, double-blind, placebo-controlled, dose-escalation study. The Abciximab in Ischemic Stroke Investigators. Stroke 2000, 31:601-609.
13. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition The GUSTO V randomised trial. The GUSTO V Investigators. Lancet 2001, 357:1905-1914.
14. Wallace RC, Furlan AJ, Moliterno DJ, et al. Basilar artery rethrombosis: Successful treatment with platelet glycoprotein IIb/IIIa receptor inhibitor. Am J Neuroradiol 1997, 18:1257-1260.
15. Qureshi AI, Suri MF, Khan J, et al. Abciximab as an adjunct to high-risk carotid or vertebrobasilar angioplasty: Preliminary experience. Neurosurgery 2000, 46:1316-1324.
16. McDonald CT, O'Donnell J, Bemporad J, et al. The clinical utility of intravenous Integrilin combined with intra-arterial tissue plasminogen activator in acute ischemic stroke: The MGH experience [abstract]. Stroke 2002, 33:359.
17. Credo RB, Burke SE, Barker WM, et al. Recombinant glycosylated pro-urokinase: Biochemistry, pharmacology, and early clinical experience. New Therapeutic Agents in Thrombosis and Thrombolysis 1997, 561-589. Marcel Dekker, New York. A.A. Sasahara, J. Loscalzo (Eds.).
18. The National Institute of Neurological Disorders and Stroke t-PA Stroke Study Group Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995, 333:1581-1587.
19. Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: The European Cooperative Acute Stroke Study (ECASS). JAMA 1995, 274:1017-1025.
20. Clark WM, Wissman S, Albers GW, et al. Recombinant tissue plasminogen activator (Altephase) for ischemic stroke 3 to 5 hours after symptom onset-the ATLANTIS Study: A randomized controlled trial. JAMA 1999, 282:2012-2026.
21. Waugh JR, Sacharis N Arteriographic complications in the DSA era. Radiology 1992, 182:243.
22. Hacke W, Kaste M, Fieschi C, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet, 1998, 352:1245-1251.
23. Wolpert SM, Bruckmann H, Greenlee R, et al. Neuroradiology evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. AJNR Am J Neuroradiol 1993, 14:3-13.
24. Pessin M, del Zoppo GJ, Furlan AJ Thrombolytic treatment in acute stroke: Review and update of selective topics. Cerebrovascular Diseases: Nineteenth Princeton Stroke Conference 1995, 409-418. Butterworth-Heinemann, Boston. M.A. Moskowitz, L.R. Caplan (Eds.).
25. Hoffman AI, Lambiase RE, Haas RA, et al. Acute vertebrobasilar occlusion: Treatment with high-dose intraarterial urokinase. AJR Am J Roentgenol 1999, 172:709-712.
26. Hacke W, Zeumer H, Ferbert A, et al. Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. Stroke 1988, 19:1216-1222.
27. Katzan IL, Masaryk TJ, Furlan AJ, et al. Intra-arterial thrombolysis for perioperative stroke after open heart surgery. Neurology 1999, 52:1081-1084.
28. Weber J, Remonda L, Mattle HP, et al. Selective intra-arterial fibrinolysis of acute central retinal artery occlusion. Stroke 1998, 29:2076-2079.
29. Padolecchia R, Puglioli M, Ragone MC, et al. Superselective intra-arterial fibrinolysis in central retinal artery occlusion. AJNR Am J Neuroradiol 1999, 20:565-567.
30. Lewandowski CA, Frankel M, Tomsick TA, et al. Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy for acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke 1999, 30:2598-2605.
31. Tomsick T, Broderick JP, Pancioli AP, et al. Combined IV-IA rtPA treatment in major acute ischemic stroke [abstract]. Stroke 2002, 33:359.
32. Brückmann H, Ferbert A, del Zoppo G, et al. Acute basilar thrombosis: Angiologic-clinical comparison and therapeutic implications. Acta Radiol 1987, 369(Suppl):38-42.
33. Katzan IL, Furlan AJ Thrombolytic therapy. Current Review of Cerebrovascular Disease 1999, 185-193. Butterworth Heinemann, Boston. 3rd ed. M. Fisher, J. Bogousslavsky (Eds.).
34. Brandt T, von Kummer R, Muller-Kuppers M, et al. Thrombolytic therapy of acute basilar artery occlusion: Variables affecting recanalization and outcome. Stroke 1996, 27:875-881.
35. Cross DT, Moran CJ, Akins P, et al. Relationship between clot location and outcome after basilar artery thrombolysis. AJNR Am J Neuroradiol 1997, 18:1221-1228.
36. Huemer M, Niederwieser V, Ladurner G Thrombolytic treatment for acute occlusion of the basilar artery. J Neurol Neurosurg Psychiatry 1995, 58:227-228.
37. Matsumoto K, Satoh K Intraarterial therapy in acute ischemic stroke. Thrombolytic Therapy in Acute Ischemic Stroke III 1995, 279-287. Springer-Verlag, Tokyo. T. Yamaguchi, E. Mori, K. Minematsu (Eds.).
38. Clark W, Barnwell S, Nesbit G, et al. Efficacy of intra-arterial thrombolysis of basilar artery stroke [abstract]. J Stroke Cerebrovasc Dis 1997, 6:457.
39. Wijdicks EF, Nichols DA, Thielen KR, et al. Intra-arterial thrombolysis in acute basilar artery thromboembolisms: The initial Mayo Clinic experience. Mayo Clin Proc 1997, 72:1005-1013.
40. Herderscheê D, Limburg M, Hijdra A, et al. Recombinant tissue plasminogen activator in two patients with basilar artery occlusion. J Neurol Neurosurg Psychiatry 1991, 54:71-73.
41. Zeumer H, Freitag HJ, Grzyska U, et al. Local Intraarterial Fibrinolysis in Acute Vertebrobasilar Occlusion. Neuroradiology, 1989, 31:336-340.
42. Becker KJ, Monsein LH, Ulatowski J, et al. Intraarterial thrombolysis in vertebrobasilar occlusion. AJNR Am J Neuroradiol 1996, 17:255-262.
43. Becker KJ, Purcell LL, Hacke W, et al. Vertebrobasilar thrombosis: Diagnosis, management, and the use of intra-arterial thrombolytics. Crit Care Med 1996, 24:1729-1742.
44. von Kummer R, Hacke W Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke. Stroke 1992, 23:646-652.
45. Mori E, Yoneda Y, Tabuchi M, et al. Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology 1992, 42:976-982.
46. Levy DE, Brott TG, Haley EC, et al. Factors related to intracranial hematoma formation in patients receiving tissue-type plasminogen activator for acute ischemic stroke. Stroke 1994, 25:291-297.
47. Kase CS, Furlan AJ, Wechsler LR, et al. Hemorrhage after intra-arterial thrombolysis for ischemic stroke: The PROACT II Trial. Neurology 2001, 57:1603-1610.
48. Bozzao L, Angeloni U, Bastianello S, et al. Early angiographic and CT findings in patients with hemorrhagic infarction in the distribution of the middle cerebral artery. AJNR Am J Neuroradiol 1991, 12:1115-1121.
49. Grotta JC, Choi D, Patel SC, et al. Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous tPA therapy. Stroke 1999, 30:1528-1533.
50. Patel SC, Levine SR, Tilley JC, et al. Lack of clinical significance of early ischemic changes on computed tomography in acute stroke. JAMA 2001, 286:2830-2838.
51. Roberts HC, Dillon WP, Furlan AJ, et al. Angiographic collaterals in acute stroke-relationship to clinical presentation and outcome: The PROACT II trial [abstract]. Stroke 2001, 32:336.
52. Kidwell CS, Saver JL, Duckwiler G, et al. Predictors of hemorrhagic transformation following intra-arterial thrombolysis [abstract]. Stroke 2001, 32:319.
53. Ueda T, Hatakeyama T, Kumon Y, et al. Evaluation of risk of hemorrhagic transformation in local intra-arterial thrombolysis in acute ischemic stroke by initial SPECT. Stroke 1994, 25:298-303.
54. Alexandrov AV, Bratina P, Grotta JC, tPA associated reperfusion after acute stroke demonstrated by HMPAO-SPECT [abstract]. Stroke 288, 1998.
55. Gore JM, Sloan M, Price TR, et al. Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study: Thrombolysis in Myocardial Infarction, Phase II, Pilot and Clinical Trial. Circulation 1991, 83:448-459.
56. Selker HP, Beshansky JR, Schmid CH, et al. Presenting pulse pressure predicts thrombolytic therapy-related intracranial hemorrhage. Thrombolytic Predictive Instrument (TPI) Project Results. Circulation 1994, 90:1657-1661.
57. Simoons ML, Maggioni AP, Knatterud G, et al. Individual risk assessment for intracranial haemorrhage during thrombolytic therapy. Lancet 1993, 342:1523-1528.
58. Gebel JM, Sila CA, Sloan MA, et al. Thrombolysis-related intracranial hemorrhage: A radiographic analysis of 244 cases from the gustol trial with clinical correlation. Stroke 1998, 29:563-569.
59. Larrue V, von Kummer R, del Zoppo G, et al. Hemorrhagic transformation in acute ischemic stroke, potential contributing factors in the European Cooperative Acute Stroke Study. Stroke 1997, 28:957-960.
60. Sloan MA, Price TR, Petito CK, et al. Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: The Thrombolysis in Myocardial Infarction (TIMI) II pilot and randomized clinical trial combined experience. Neurology 1995, 45:649-658.
61. Hacke W Thrombolysis: Stroke subtype and embolus type. Thrombolytic Therapy in Acute Ischemic Stroke II 1993, 153-159. Springer-Verlag, Berlin. G.J. del Zoppo, E. Mori, W. Hacke (Eds.).
62. von Kummer R, Holle R, Rosin L, et al. Does arterial recanalization improve outcome in carotid territory stroke?. Stroke 1995, 26:581-587.
63. Ringelstein EB, Biniek R, Weiler C, et al. Type and extent of hemispheric brain infarctions and clinical outcome in early and delayed middle cerebral artery recanalization. Neurology 1991, 42:289-298.
64. Chimowitz M, Pessin M, Furlan A, et al. The effect of source of cerebral embolus on susceptibility to thrombolysis [abstract]. Neurology 1994, 44(Suppl 2):A356.
65. Caplan LR, Mohr JP, Kistler JP, Koroshetz W Thrombolysis-not a panacea for ischemic stroke. N Engl J Med 1997, 337:1309.
66. Wardlaw JM, Warlow CP, Counsell C Systematic review of evidence on thrombolytic therapy for acute ischaemic stroke. Lancet 1997, 350:607-614.
67. Gönner F, Remonda L, Mattle H, et al. Local intra-arterial thrombolysis in acute ischemic stroke. Stroke 1998, 29:1894-1900.
68. Ueda T, Sakaki S, Nochide I, et al. Angioplasty after intra-arterial thrombolysis for acute occlusion of intracranial arteries. Stroke 1998, 29:2568-2574.
69. Mori T, Kazita K, Chokyu K, et al. Short-term arteriographic and clinical outcome after cerebral angioplasty and stenting for intracranial vertebrobasilar and carotid atherosclerotic occlusive disease. AJNR Am J Neuroradiol 2000, 21:249-254.
70. Nakayama T, Tanaka K, Kaneko M, et al. Thrombolysis and angioplasty for acute occlusion of intracranial vertebrobasilar arteries: Report of three cases. J Neurosurg 1998, 88:919-922.
71. Tsai FY, Berberaj B, Matovich V, et al. Percutaneous transluminal angioplasty adjunct to thrombolysis for acute middle cerebral artery rethrombosis. AJNR Am J Neuroradiol 1994, 15:1823-1829.
72. Chopko BW, Kerber C, Wong W, Georgy B Transcatheter snare removal of acute middle cerebral artery thromboembolism: Technical case report. Neurosurgery 2000, 40:1529-1531.
73. Phatouros CC, Higashida RT, Malek AM, et al. Endovascular stenting of an acutely thrombosed basilar artery: Technical case report and review of the literature. Neurosurgery 1999, 44:667-673.
74. Alexandrov AV, Demchuk AM, Felberg RA, et al. High rate of complete recanalization and dramatic clinical recovery during tPA infusion when continuously monitored with 2-MHz transcranial Doppler monitoring. Stroke 2000, 31:610-614.
75. Lempert TE, Halbach VV, Malek AM, et al. Rescue treatment of acute parent vessel thrombosis with glycoprotein IIb/IIIa inhibitor during GDC coil embolization. Stroke 1999, 30:693-695.
76. Cochrane Database of Systematic Reviews, Issue 4, 1999.
77. Keir SL, Wardlaw JM Systematic review of diffusion and perfusion imaging in acute ischemic stroke. Stroke 2000, 31:2723-2731.
78. Fisher M, Albers GW Applications of diffusion-perfusion magnetic resonance imaging in acute ischemic stroke. Neurology 1999, 52:1750-1756.
79. Hacke W, Warach S Diffusion-weighted MRI as an evolving standard of care in acute stroke. Neurology 2000, 54:1548-1549.
80. Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Part 7: The era of reperfusion. section 2: Acute stroke. The American Heart Association in collaboration with the International Liaison Committee on Resuscitation. Circulation 2000, 102(Suppl):I204-I216.
81. Emergency interventional stroke therapy A statement from the American Society of Interventional and Therapeutic Neuroradiology and Society of Cardiovascular and Interventional Radiology. Am J Neuroradiol 2001, 22:54.
82. INSTOR Interventional Stroke Therapy Outcomes Registry. Available online at . http://www.strokeregistry.org/.
83. Boden WE, McKay RG Optimal treatment of acute coronary syndromes-an evolving strategy. N Engl J Med 2001, 344:1939-1942.